IDH2 and acute myeloid leukemia: The presence ofIDH mutations in benign enchondromas and malignant CS supports the notion thatIDH mutations are an early event, and these cartilaginous neoplasms represent a spectrum of malignant potential.IDH mutations are found in gliomas, acute myeloid leukemia (AML), and cholangiocarcinomas24.